A Prospective, Non-randomized, Single Cohort, Multicenter Study to Evaluate the Clinical Outcomes of Total Knee Arthroplasty (TKA) Using the JOURNEY™ II CR Total Knee System

Study Description

The purpose of this study is to evaluate the safety and effectiveness of the JOURNEY™ II CR Total Knee System in subjects with degenerative joint disease (DJD) requiring primary total knee replacement.

Study Details

Registry ID:

NCT02440672

Conditions:

Osteoarthritis, Knee

Phase:

Target Enrollment:

170 participants

Start Date:

September 1, 2015

Age Range:

22–75 years

Healthy Volunteers:

No

Study Locations (10 sites)

• Hospital Parc Taulí Servei de Cirurgia Ortopèdica I Traumatologia
  Barcelona, BarcelonaSpain, Spain
• Hospital Parc Taulí Servei de Cirurgia Ortopèdica I Traumatologia
  BarcelonaSpain, Spain
• Barts Health NHS Trust
  WhitechapelUnited Kingdom, United Kingdom
• Royal National Orthopaedic Hospital NHS Trust
  StanmoreUnited Kingdom, United Kingdom
• Center for Hip and Knee Replacement at Columbia University Medical Center
  New York, New YorkUnited States, United States
• Anne Arundel Health System Research Institute, Inc
  Annapolis, MarylandUnited States, United States
• Wake Forest University
  Winston-Salem, North CarolinaUnited States, United States
• The Lindner Research Center, Musculo-Skeletal Division - The Christ Hospital Health Network
  Cincinnati, OhioUnited States, United States
• Rush University Medical Center
  Chicago, IllinoisUnited States, United States
• Orthopedic Institute of the West
  Phoenix, ArizonaUnited States, United States

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →